Oncological safety and preventive impact of nipple-sparing mastectomy in patients with BRCA1/2 mutation: multicentre study of the Korea Robot-endoscopy Minimal Access Breast Surgery Study Group (KoREa-BSG)
BJS Open · 2025
DOI: 10.1093/bjsopen/zraf168 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift BJS Open, 2025. Verfasst von Hong-Kyu Kim und 25 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea. Hauptthemen laut MEDLINE: Breast Neoplasms, Prophylactic Mastectomy, Mastectomy. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Korean Society of Surgical Oncology.
Abstract (Originalsprache)
Background
Nipple-sparing mastectomy (NSM) is a surgical option offering both oncological safety and cosmetic benefits. However, the oncological safety of NSM in carriers of BRCA1/2 pathogenic variants/likely pathogenic variants (PV/LPV) with breast cancer and the role of risk-reducing mastectomy remain underexplored, especially in Asian populations. This study evaluated the safety and effectiveness of NSM in BRCA1/2 PV/LPV carriers and assessed the preventive impact of contralateral risk-reducing NSM (RRNSM) on cancer incidence.
Methods
This multicentre retrospective study included women aged 20–80 years who underwent NSM for therapeutic or risk-reducing purposes and received germline BRCA1/2 tests between May 2006 and June 2022 across 19 institutions in Korea. Patients with distant metastasis at diagnosis were excluded. Information on demographics, the clinical characteristics of patients and tumours, surgical details, and follow-up outcomes was collected from a review the medical records of each participating institution. The primary outcome was the oncological safety of NSM, assessed by comparing ipsilateral local recurrence rates between patients with and without BRCA1/2 PV/LPV. The secondary outcome was cancer incidence in patients who underwent contralateral RRNSM versus those who did not.
Results
In all, 787 women underwent 906 NSMs, with a median (interquartile range) follow-up of 59.3 (44.0–82.8) months. Among the participants, 186 (23.6%) were BRCA1/2 PV/LPV carriers. Ipsilateral local recurrence rates were comparable between BRCA1/2 PV/LPV carriers and non-carriers (6.4 versus 7.4%, respectively). The 5-year local recurrence-free survival rates did not differ significantly between BRCA1/2 PV/LPV carriers and non-carriers (92.2% versus 93.2%, respectively; P = 0.87). Contralateral breast cancer occurred in 4.5% of patients with BRCA1/2 PV/LPV who did not undergo contralateral RRNSM, whereas no cases of contralateral breast cancer were reported among patients who underwent RRNSM regardless of BRCA1/2 status.
Conclusions
This study highlights NSM as a safe and effective surgical option for BRCA1/2 PV/LPV carriers with breast cancer, as well as a risk-reducing strategy. Further prospective studies are needed to confirm these findings and evaluate long-term outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Surgery, Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea.
- Division of Breast Surgery, Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
- Division of Breast Surgery, Department of Surgery, Jeju National University Hospital, Jeju National University School of Medicine, Jeju, Korea.
- Department of Surgery, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.
- Department of Surgery, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea.
- Department of Surgery, Hanyang University Medical Center, Hanyang University College of Medicine, Seoul, Korea.
ORCID-Profile: Dong Seung Shin, Hee-Chul Shin
Förderung
- Korean Society of Surgical Oncology
Zitieren
APA
Kim, H. K., Shin, D. S., Jang, S. Y., Bae, S. J., Kim, E. Y., Cha, C. D., Park, H. S., Lee, J., Lee, J. H., Lee, E. S., Choi, J. E., Bae, S. Y., Shin, H. C., Kim, D., Lee, M. H., Kim, Y. Y., Han, S. A., Lee, J., Chang, Y. W., …, & Korea Robot-endoscopy Minimal Access Breast Surgery Study Group (KoREa-BSG) (2025). Oncological safety and preventive impact of nipple-sparing mastectomy in patients with BRCA1/2 mutation: multicentre study of the Korea Robot-endoscopy Minimal Access Breast Surgery Study Group (KoREa-BSG). BJS Open. https://doi.org/10.1093/bjsopen/zraf168
Vancouver
Kim HK, Shin DS, Jang SY, Bae SJ, Kim EY, Cha CD, et al. Oncological safety and preventive impact of nipple-sparing mastectomy in patients with BRCA1/2 mutation: multicentre study of the Korea Robot-endoscopy Minimal Access Breast Surgery Study Group (KoREa-BSG). BJS Open. 2025. doi:10.1093/bjsopen/zraf168
BibTeX
@article{Kim2025,
author = {Kim, Hong-Kyu and Shin, Dong Seung and Jang, Sung Yoon and Bae, Soong June and Kim, Eun Young and Cha, Chihwan David and Park, Hyung Seok and Lee, Jeeyeon and Lee, Jun-Hee and Lee, Eun-Shin and Choi, Jung Eun and Bae, Soo Youn and Shin, Hee-Chul and Kim, Dongwon and Lee, Moo Hyun and Kim, Yong-Yeup and Han, Sang-Ah and Lee, Janghee and Chang, Young Woo and Min, Junwon and Kim, Sanghwa and Kang, Young-Joon and Choi, Hee Jun and Lee, Sae Byul and Ryu, Jai Min and Korea Robot-endoscopy Minimal Access Breast Surgery Study Group (KoREa-BSG), Korea Robot-endoscopy Minimal Access Breast Surgery Study Group (KoREa-BSG)},
title = {Oncological safety and preventive impact of nipple-sparing mastectomy in patients with BRCA1/2 mutation: multicentre study of the Korea Robot-endoscopy Minimal Access Breast Surgery Study Group (KoREa-BSG)},
journal = {BJS Open},
year = {2025},
doi = {10.1093/bjsopen/zraf168}
}
EUVIMED